1,206% Growth from FDA-Approved Cannabis Stock
| Leave a CommentGW Pharmaceuticals’ quarterly sales soared to $39.2 million, a 1,206% jump from last year. The cannabis drug maker got FDA approval for its drug last June. Read more
Read more »GW Pharmaceuticals’ quarterly sales soared to $39.2 million, a 1,206% jump from last year. The cannabis drug maker got FDA approval for its drug last June. Read more
Read more »